A lawsuit was filed on behalf of investors in Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) shares over alleged securities laws violations. Deadline: October 6, 2014. OTCMKTS:NVIV investors should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 08/13/2014 -- An investor, who purchased shares of Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Invivo Therapeutics Holdings Corp in connection with certain allegedly false and misleading statements made between April 5, 2013 and August 26, 2013.
Investors who purchased shares Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) have certain options and for certain investors are short and strict deadlines running. Deadline: October 6, 2014. OTCMKTS:NVIV investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint the plaintiff alleges on behalf of purchasers of Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) common shares between April 5, 2013 and August 26, 2013, that the defendants violated Federal Securities Laws.
More specifically, the plaintiff claims that the defendants made allegedly false and misleading statements about the FDA's approval of a clinical trial and the time for completion of the trial and submission of data to the FDA.
Shares of Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) grew from $1.37 per share in October 2012 to as high as $5.49 per share in July 2013.
Then on August 27, 2013, Invivo Therapeutics Holdings Corp announced an update on the clinical timeline for its biopolymer scaffolding to treat acute SCI.
Shares of Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) declined from $4.11 on August 20, 2014, to $1.19 per share on August 30, 2013.
Invivo Therapeutics Holdings Corp reported that its Net Income of $4.66 million in 2012 declined to a Net Loss of $38.76 million in 2013.
On August 11, 2014, OTCMKTS:NVIV shares closed $0.790 per share.
Those who purchased shares of Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com